Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Importance of the renal ion channel TRPM6 in the circadian secretion of renin to raise blood pressure

Abstract

Blood pressure has a daily pattern, with higher values in the active period. Its elevation at the onset of the active period substantially increases the risk of fatal cardiovascular events. Renin secretion stimulated by renal sympathetic neurons is considered essential to this process; however, its regulatory mechanism remains largely unknown. Here, we show the importance of transient receptor potential melastatin-related 6 (TRPM6), a Mg2+-permeable cation channel, in augmenting renin secretion in the active period. TRPM6 expression is significantly reduced in the distal convoluted tubule of hypotensive Cnnm2-deficient mice. We generate kidney-specific Trpm6-deficient mice and observe a decrease in blood pressure and a disappearance of its circadian variation. Consistently, renin secretion is not augmented in the active period. Furthermore, renin secretion after pharmacological activation of β-adrenoreceptor, the target of neuronal stimulation, is abrogated, and the receptor expression is decreased in renin-secreting cells. These results indicate crucial roles of TRPM6 in the circadian regulation of blood pressure.

Introduction

Approximately one billion people worldwide are estimated to have hypertension, which significantly increases the risk of various diseases, including potentially fatal diseases, such as ischemic heart disease and stroke. These hypertension-related fatal incidents are known to occur frequently in the early morning, the beginning of the active period when blood pressure rises sharply1. Renin secretion triggered by renal sympathetic neurons is considered to play a crucial role in this blood pressure elevation, but its regulatory mechanism is not well understood2.

It is widely accepted that some dietary minerals, particularly sodium and potassium, play important roles in the control of blood pressure. Magnesium is a major essential element involved in a variety of biological activities. Epidemiological studies have shown a significant inverse relationship between dietary magnesium levels and the risk of hypertension3,4,5,6. Moreover, urinary magnesium excretion, which is assumed to be in approximate equilibrium with intestinal magnesium absorption, is inversely correlated with the risk of hypertension7. These findings suggest a close association between organismal magnesium homeostasis and blood pressure regulation, highlighting the importance of Mg2+ channels and/or transporters in the regulation of blood pressure.

A large quantity of magnesium is constantly being reabsorbed in the kidney. Most magnesium in the glomerular filtrate is reabsorbed in the thick ascending limb of Henle’s loop, but the final step of reabsorption occurs at the distal convoluted tubule (DCT)8. The latter process is tightly regulated to adjust the amount of reabsorption to a level appropriate for maintaining magnesium homeostasis. Genomic analyses of congenital diseases with symptoms of hypomagnesemia have revealed several key molecules involved in this process. Trpm6, encoding transient receptor potential melastatin-related 6 (TRPM6), is mutated in patients with recessive hypomagnesemia with secondary hypocalcemia9,10. TRPM6 forms a Mg2+-permeable ion channel localized to the apical membrane of DCT cells and mediates Mg2+ intake from the tubular lumen11. Another key molecule is cyclin M2 (CNNM2), a Mg2+ transporter localized to the basolateral membrane of DCT cells12,13. Cnnm2 mutations cause familial dominant hypomagnesemia, which is characterized by defects in magnesium reabsorption in the kidney12. Cnnm2-deficient mice show similar symptoms of hypomagnesemia with magnesium wasting in the kidney14. The precise molecular role of CNNM2 is still controversial, but several lines of evidence suggest that it mediates Mg2+ efflux from DCT cells through the basolateral membrane15, thereby contributing to magnesium reabsorption. Further analyses of Cnnm2-deficient mice have revealed that these mice also have significantly lower blood pressure than control mice14. However, the mechanistic details and the involvement of other Mg2+ channels/transporters in this blood pressure regulation remain unknown.

The renal DCT is also known to play critical roles in blood pressure regulation, because it significantly reabsorbs sodium and regulates body fluid volume16. A number of cation channels/transporters, such as the Na-Cl co-transporter (NCC), epithelial sodium channel (ENaC), and Na+/H+ exchanger 2 (NHE2), are expressed at the DCT apical membrane and some of these proteins mediate Na+ intake into DCT cells from the tubular lumen. Intracellular Na+ is then extruded from the cells through the basolateral membrane by Na+/K+-ATPase to accomplish its reabsorption. Apart from a direct involvement in regulating body fluid volume, the DCT is located adjacent to the macula densa, which controls secretion of renin, a hormone with the principal role in orchestrating blood pressure regulation17,18. By sensing urinary Cl levels, macula densa cells stimulate nearby juxtaglomerular (JG) cells to secrete renin.

In this work, we perform transcriptome analyses with kidneys of hypotensive Cnnm2-deficient mice. We find a significant decrease of Trpm6, prompting us to generate kidney-specific Trpm6-deficient mice. Unexpectedly, analyses of this mouse strain reveal a phenotype qualitatively different from that of Cnnm2-deficient: the loss of circadian variation of blood pressure. We also find that this phenotype is caused by impaired secretion of renin, a blood pressure-raising hormone of which blood level is normally elevated during the active phase.

Results

Downregulation of TRPM6 expression in Cnnm2-deficient mice

To explore the molecular mechanism of blood pressure reduction in Cnnm2-deficient mice, we performed DNA microarray analyses to investigate gene expression changes in the kidney of Cnnm2fl/fl;Six2-Cre mice, lacking both Cnnm2 alleles in the kidney14. Among the differentially expressed genes (Table 1), we chose to analyze Pvalb and Trpm6, both of which are expressed in the DCT9,19. Quantitative PCR (qPCR) analyses revealed that Trpm6 expression was similarly reduced in the kidneys of both Cnnm2fl/fl;Six2-Cre and Cnnm2+/Δ mice (Supplementary Fig. 1a). Since both Cnnm2+/Δ and Cnnm2fl/fl;Six2-Cre mice were hypotensive14, we analyzed TRPM6 expression in more detail. Immunoblotting analyses of kidney lysates confirmed a significant decrease of TRPM6 at the protein level by Cnnm2-deficiency, while the levels of NCC and phosphorylated NCC (active form) were not markedly affected (Supplementary Fig. 1b, CNNM2 expression was confirmed by successive immunoprecipitation and immunoblotting analyses). The decrease of TRPM6 in the kidneys of Cnnm2fl/fl;Six2-Cre mice was also confirmed by immunofluorescence analyses (Supplementary Fig. 1c).

Table 1 Genes that were upregulated or downregulated in the kidneys of Cnnm2fl/fl;Six2-Cre mice.

We also examined TRPM6 expression in mice lacking CNNM4, which also show symptoms of hypomagnesemia20 but have elevated blood pressure14. Immunoblotting and immunofluorescence analyses indicated that TRPM6 expression is augmented in DCT cells of Cnnm4-deficient mice (Supplementary Fig. 1d, e), suggesting that TRPM6 expression is closely associated with blood pressure values, but it is not directly linked to blood magnesium levels.

Regulation of TRPM6 expression by intracellular Mg2+ in DCT cells

To characterize the molecular mechanism of TRPM6 downregulation in Cnnm2-deficient mice, we used a DCT-derived cell line MDCT21, which expresses dominantly Cnnm2 and moderately Cnnm3 and Cnnm4 among Cnnm family genes (Cnnm1Cnnm4, Supplementary Fig. 1f). As CNNM2 and CNNM4 have strong Mg2+ efflux activity while CNNM3 has no Mg2+ efflux activity15, we performed small-interfering RNA (siRNA)-mediated knockdown of either Cnnm2, Cnnm4, or both. Cnnm2 knockdown augmented intracellular Mg2+ levels ([Mg2+]i), and simultaneous knockdown of Cnnm4 led to slight elevation of average [Mg2+]i value, which was not statistically significant (Supplementary Fig. 1g). We next examined Trpm6 expression by qPCR and found a significant decrease after Cnnm2 knockdown and a much larger decrease after double knockdown of Cnnm2 and Cnnm4. Therefore, Trpm6 expression appears to be negatively regulated by intracellular Mg2+ levels, which is consistent with previous reports22,23. To directly examine the importance of Mg2+, we cultured MDCT cells in media with various concentrations of Mg2+. As shown in Supplementary Fig. 1h, decreasing the extracellular Mg2+ concentration led to the reduction in intracellular Mg2+ level and the increase of Trpm6 expression, suggesting a suppressive role of Mg2+. In the case of double knockdown (Cnnm2/Cnnm4) MDCT cells, Trpm6 expression was suppressed with decreasing Mg2+ concentrations down to 0.2 mM, but further reductions canceled the suppressive effect; both intracellular Mg2+ and Trpm6 levels were not significantly different from control siRNA-transfected cells in both 0.1 and 0.02 mM conditions. These results indicate a Mg2+-dependent regulatory mechanism of Trpm6 expression, which explains the Trpm6 downregulation in the kidneys of Cnnm2-deficient mice.

Conditional disruption of Trpm6 in the kidney

Next, we aimed to generate Trpm6-deficient mice to further investigate the importance TRPM6 in the regulation of blood pressure. We used an embryonic stem (ES) cell clone carrying a recombinant Trpm6 allele (Trpm6) that contains a splice acceptor sequence, forcing premature mRNA splicing and resulting in an mRNA truncated after exon 6 (Supplementary Fig. 2a). Chimeric heterozygous mice were obtained by blastocyst injection of the ES cells and recombination was confirmed by PCR (Supplementary Fig. 2b). We intercrossed these Trpm6+/− mice, but no Trpm6−/− offspring were obtained (Supplementary Fig. 2c). This result is consistent with previous reports showing embryonic lethality in Trpm6-deficient mice24,25.

Therefore, we performed a kidney-specific conditional disruption of Trpm6 using Six2-Cre, which enables efficient and specific expression of GFP-fused Cre recombinase in the embryonic kidney (ref. 26 and Supplementary Fig. 3). Trpm6fl/fl;Six2-Cre mice (kidney-specific Trpm6-deficient mice) were born at the expected Mendelian ratio (Supplementary Fig. 2c). To determine the expression of TRPM6, we performed immunoblotting analyses using an anti-TRPM6 antibody. TRPM6 protein levels were greatly reduced in the kidneys of Trpm6fl/fl;Six2-Cre mice, but no significant changes were observed in other organs (Fig. 1a). Immunofluorescence staining analyses also showed no expression of TRPM6 in NCC-positive DCT cells (Fig. 1b). We observed no significant TRPM6-positive signal in more than 100 such clusters of NCC-positive cells, suggesting that TRPM6 expression is almost completely suppressed in DCT cells of Trpm6fl/fl;Six2-Cre mice. These results confirm the successful generation of kidney-specific Trpm6-deficient mice.

Fig. 1: Disrupted magnesium homeostasis in Trpm6-deficient mice.
figure1

a Lysates obtained from various organs of 2-month-old Trpm6+/+;Six2-Cre and Trpm6fl/fl;Six2-Cre mice were subjected to immunoblotting with an anti-TRPM6 antibody. A representative result from two independent experiments with similar results are shown. b Cryosections of 2-month-old Trpm6+/+;Six2-Cre and Trpm6fl/fl;Six2-Cre mice were subjected to immunofluorescence staining with an anti-TRPM6 antibody (green), an anti-NCC antibody (red), and DAPI (blue). Bar, 20 μm. A representative result from three independent experiments with similar results are shown. c Colorimetric quantitation of magnesium (Mg) in serum and urine samples obtained from 2- to 3-month-old mice of Trpm6+/+;Six2-Cre and Trpm6fl/fl;Six2-Cre mice. Data are shown as means ± SEM (from left to right, n = 7, 8, 7, 9 mice). The p-values were determined by Student’s two-tailed t-tests (unpaired). *p <  0.05, **p < 0.01. d Serum samples were subjected to elemental analyses using ICP-ES. Data are shown as means ± SEM (n = 10 for Trpm6+/+;Six2-Cre mice and n = 12 for Trpm6fl/fl;Six2-Cre mice). The p-values were determined by Student’s two-tailed t-tests (unpaired). *p < 0.05.

We first examined the effect of kidney-specific Trpm6-deficiency on magnesium homeostasis. We maintained mice in metabolic cages and collected urine and serum samples, which were then subjected to colorimetric quantitation of magnesium levels using Xylidyl Blue-I. Serum magnesium levels were significantly lower in Trpm6fl/fl;Six2-Cre mice compared to those in control Trpm6+/+;Six2-Cre mice, whereas urinary magnesium levels were higher (Fig. 1c). We also performed inductively coupled plasma-emission spectroscopy (ICP-ES) analyses to measure several major metal elements in the serum and found that only magnesium levels were significantly affected in Trpm6fl/fl;Six2-Cre mice (Fig. 1d). These results clearly indicate that kidney-specific Trpm6-deficient mice have hypomagnesemia with renal magnesium wasting, as observed in kidney-specific Cnnm2-deficient mice14.

Lack of circadian variation of blood pressure and renin activity

Next, we subjected Trpm6fl/fl;Six2-Cre mice to blood pressure measurements using radiotelemetry. Systolic and diastolic blood pressure values were both significantly lower in Trpm6fl/fl;Six2-Cre mice than control mice (Fig. 2a and Supplementary Fig. 4). It is noteworthy that the usual circadian variation of blood pressure, with high values during the dark period and low values during the light period in mice, was not observed in Trpm6fl/fl;Six2-Cre mice. To examine whether the circadian rhythm proceeds normally, we used radiotelemetry to measure the locomotive activity of mice and confirmed a very clear circadian variation in Trpm6fl/fl;Six2-Cre mice (Fig. 2b). We also examined blood levels of vasopressin (AVP) and mRNA levels of two clock genes Bmal1 and Per2 in the brain and kidney; all are known to show typical circadian variation27,28. We analyzed at six different time points (at 0, 4, 8 zeitgeber times (ZT) for the light period and at 12, 16, 20 ZT for the dark period). Control mice show clear circadian patterns of their expression as previously reported28, and again, we found no significant abnormalities in Trpm6fl/fl;Six2-Cre mice (Fig. 2c and Supplementary Fig. 5). We also checked the expression level of Trpm7, which encodes an Mg2+-permeable channel closely related to TRPM6, in the kidney. The expression patterns were very similar in both Trpm6+/+;Six2-Cre and Trpm6fl/fl;Six2-Cre mice, and did not show clear circadian patterns (Supplementary Fig. 5). Collectively, we conclude that the circadian rhythm proceeds normally in Trpm6fl/fl;Six2-Cre mice. It has been considered that blood pressure elevation during the active period (the dark period for mice and the light period for humans) in both humans and mice occurs in response to an increase in renin secretion into the blood2. We measured renin activity in blood samples collected at the six different time points described above. A clear increase in blood renin activity was observed during the dark periods in samples from control mice, but no significant increase was observed in samples from those of Trpm6fl/fl;Six2-Cre mice (Fig. 2d). We also measured the blood level of noradrenaline, the release of which is known to be stimulated by the activation of renin–angiotensin system29,30. As expected, their circadian variation also disappeared in Trpm6fl/fl;Six2-Cre mice (Fig. 2e). Meanwhile, the protein level of blood angiotensinogen (AGT), another rate limiting molecule for activating renin–angiotensin system in mice31, was unaffected by Trpm6 deficiency (Supplementary Fig. 6). The results suggest that the impaired circadian variation of renin is important for the loss of circadian variation of blood pressure by Trpm6-deficiency.

Fig. 2: Trpm6 ablation impairs circadian rhythms of blood pressure and renin activity.
figure2

a Blood pressure values of 2- to 3-month-old mice of the indicated genotypes were measured with radiotelemetry. Data are shown as means ± SEM for systolic (left) and diastolic (right) pressure values (n = 4 for Trpm6+/+; Six2-Cre and n = 3 for Trpm6fl/fl; Six2-Cre). The p-values were determined by two-way ANOVA with Holm-Sidak post hoc tests. *p < 0.05. b Locomotor activity of 2- to 3-month-old mice of the indicated genotypes. Data are shown as means ± SEM (n = 3 mice for each genotype). ce Whole blood was collected from 2- to 4-month-old mice of the indicated genotypes at indicated time periods, and plasma AVP (c, n = 3 mice for each genotype), renin activity (d, n = 5 at ZT0 and ZT4, n = 6 for Trpm6+/+; Six2-Cre and n = 4 for Trpm6fl/fl; Six2-Cre at ZT8, n = 3 at ZT12, ZT16, and ZT20), and noradrenaline (e, n = 4 at ZT0, ZT4, and ZT8, and n = 3 at ZT12, ZT16, and ZT20) were measured. Data are shown as means ± SEM. The p-values were determined by two-way ANOVA with Holm-Sidak post hoc tests. *p < 0.05, **p < 0.01, ***p < 0.001.

Proximity of TRPM6-expressing cells to renin-secreting cells

Renin is expressed in and secreted from JG cells in the kidney17,18. JG cells are in direct contact with the macula densa, which is located adjacent to the DCT and which stimulates renin secretion from JG cells in response to the reduction of urinary Cl levels18. Immunofluorescence staining for renin and neuronal nitric oxide synthase (nNOS), a macula densa marker, showed no abnormalities in either the pattern or intensity of positive signals observed near the glomeruli in Trpm6fl/fl;Six2-Cre mice (Fig. 3a). Therefore, cells directly involved in renin secretion and its regulation do not seem to be markedly affected by Trpm6 deficiency. As TRPM6 is co-expressed with NCC in the DCT (Supplementary Fig. 1c), we next examined the spatial relationship between TRPM6/NCC-expressing cells (DCT) and the macula densa or JG cells. Confocal images of sagittal DCT sections showed almost a complete overlap of TRPM6 and NCC signals throughout the DCT (Fig. 3b). We then stained for nNOS and NCC, and found that the areas positive for nNOS and NCC are connected, without any signal overlap (Fig. 3c). In addition, double staining for renin and TRPM6/NCC revealed that some TRPM6/NCC-expressing cells are in proximity to renin-expressing JG cells (Fig. 3d, e), suggesting that TRPM6/NCC-expressing cells, as well as the macula densa, may have a significant impact on renin secretion.

Fig. 3: TRPM6-expressing cells are adjacent to renin-secreting cells.
figure3

a Cryosections of 2-month-old Trpm6+/+;Six2-Cre and Trpm6fl/fl;Six2-Cre mouse kidneys were subjected to immunofluorescence staining with an anti-renin antibody (green), an anti-nNOS antibody (red), and DAPI (blue). Bar, 20 μm. A representative result from three independent experiments with similar results are shown. be Cryosections of 2-month-old Trpm6+/+;Six2-Cre mouse kidneys were subjected to immunofluorescence staining with the indicated antibodies and DAPI (blue). Merged images and monochrome images of each antibody staining are shown. Bar, 20 μm. A representative result from three independent experiments with similar results are shown.

Impaired renin secretion by Trpm6 deficiency

In general, the autonomic nervous system plays a crucial role in orchestrating the progression of the circadian rhythm. Renin secretion from JG cells during the active period is thought to be stimulated by noradrenalin secreted from renal sympathetic neurons32. To directly investigate the effect of such stimulation on renin secretion, we prepared kidney slices and stimulated them with isoproterenol, a β-adrenoreceptor (AR) agonist. Results showed a very clear decrease in renin-positive signal remaining in the slice after isoproterenol stimulation for 30 min (Fig. 4a). Quantitative analyses showed that the percentage of glomeruli surounded by renin-positive signal decreased from approximately 80% to 30% after isoproterenol stimulation (Fig. 4b), indicating the occurrence of massive renin secretion. However, we did not observe a significant effect of isoproterenol stimulation on renin signal in kidney slices from Trpm6fl/fl;Six2-Cre mice. To confirm the result, we also measured the blood renin activity after isoproterenol administration. The results show that significant elevation of blood renin activity was only observed in control mice (Fig. 4c), while the increase of heart rate was commonly observed in both strains (Supplementary Fig. 7). These results imply that renin-secreting JG cells cannot respond to stimulation from renal sympathetic neurons, consistent with the disappearance of the circadian increase in blood pressure and renin activity in Trpm6fl/fl;Six2-Cre mice.

Fig. 4: Impaired renin secretion upon adrenergic stimulation.
figure4

a Slices of kidneys dissected from 2- to 3-month-old mice of the indicated genotypes were incubated with the indicated chemicals for 30 min and cryosections of these kidney slices were subjected to immunofluorescence staining with an anti-renin antibody (green), an anti-nNOS antibody (red), and DAPI (blue). Arrowheads indicate renin-positive cells. Bar, 20 μm. A representative result from three independent experiments with similar results are shown. b The percentages of glomeruli with adjacent renin-positive cells are shown as means ± SEM (in both genotype, n = 6 (mock), 6 (Isoproterenol), 4 (PGE2), and 2 (db-cAMP)). The p-values were determined by two-way ANOVA with Holm-Sidak post hoc tests. ***p < 0.001. c 2- to 3-month-old mice of the indicated genotypes were intraperitoneally administered with 10 mg/kg isoproterenol, and plasma collected the day before and 30 min after drug administration were subjected to renin activity measurement (n = 4 for Trpm6+/+; Six2-Cre, and n = 8 for Trpm6fl/fl; Six2-Cre). Data are shown as means ± SEM. The p-values were determined by two-way ANOVA with Holm-Sidak post hoc tests. *p < 0.05.

JG cells can also be stimulated to secrete renin in response to prostaglandins, among which prostaglandin E2 (PGE2) is considered most significant since it is physiologically secreted by macula densa cells when urinary Cl levels decrease17,18. Moreover, it is also known that PGE2 treatment of kidney slices can stimulate renin secretion efficiently33. Stimulation of JG cells with PGE2 and isoproterenol commonly activates cAMP production, which ultimately causes renin secretion. Therefore, we also tested the effect of PGE2 and the membrane-permeable cAMP analog, dibutylyl-cAMP (db-cAMP). PGE2 and db-cAMP successfully stimulated renin secretion in kidney slices from Trpm6fl/fl;Six2-Cre mice and control mice (Fig. 4a, b). This indicates that Trpm6 deficiency does not abrogate the general machinery involved in sensing external cues, relaying intracellular signals, and executing renin secretion, but it specifically affects the response to β-AR.

Decreased β-AR expression in JG cells by Trpm6 deficiency

Impaired β-AR receptor response (Fig. 4) in Trpm6fl/fl;Six2-Cre mice led us to investigate the status of the β-AR receptor expression, and thus we performed immunofluorescence of β1-AR, the major β-AR subtype expressed in JG cells34. As reported previously34, we found the band-like staining pattern in renal sections of both control and Trpm6fl/fl;Six2-Cre mice (Fig. 5a, b). It is known that β1-AR is strongly expressed in both blood vessel and JG cells34, and consistently, the β1-AR-positive cells at the end of the band-like staining in control mouse kidney were also positive for renin staining (shown with an arrowhead). In contrast, staining of Trpm6fl/fl;Six2-Cre mouse kidney showed a smaller number of β1-AR/renin double-positive cells, suggesting that β1-AR expression was decreased in JG cells. To corroborate this finding, we isolated JG cells by using Percoll density gradient centrifugation method according to the previous report35 (Fig. 5c). Immunoblotting analyses revealed that renin-positive JG cells are enriched in band 3 fraction, which is consistent with their report35, and β1-AR expression in this band 3 fraction was specifically much lower in Trpm6fl/fl;Six2-Cre mice. Taken together, we found that Trpm6 deficiency decreases the expression level of β1-AR in JG cells, which is consistent with the impaired renin secretion.

Fig. 5: Decreased β1-AR expression in JG cell.
figure5

a Cryosections of 2-month-old Trpm6+/+;Six2-Cre and Trpm6fl/fl;Six2-Cre mouse kidneys were subjected to immunofluorescence staining with an anti-renin antibody (green), an anti-β1-AR antibody (red), and DAPI (blue). Bar, 20 μm. A representative result from three independent experiments with similar results are shown. b The percentages of glomeruli with adjacent renin/β1-AR-double-positive cells are shown as means ± SEM (n = 3). The p-values were determined by Student’s two-tailed t-tests (unpaired). ***p < 0.001. c Kidneys dissected from 2-month-old Trpm6+/+;Six2-Cre and Trpm6fl/fl;Six2-Cre mice were treated with trypsin and collagenase, and dispersed cells were separated using Percoll density gradient centrifugation. Cells in each band were collected, and the cell lysates were subjected to immunoblotting with indicated antibodies. Arrowhead and arrow indicate precursor and processed mature form, respectively. A representative result from three independent experiments with similar results are shown.

The effect of artificial intervention on circadian blood pressure variation

In the final set of experiments, we tested the effect of various interventions on circadian blood pressure variation. To confirm the importance of renin, we administered a clinically available renin inhibitor aliskiren36 to wild-type mice (Fig. 6a). Like Trpm6 ablation, aliskiren administration by surgically implanting an osmotic minipump significantly suppressed the circadian blood pressure variation. Next, we performed renal denervation operations, since the activation of β-AR on JG cells through the sympathetic nervous system is the major pathway for stimulating renin secretion in a circadian manner32 (Fig. 6b). Again, we found that the intervention suppressed the blood pressure variation. These results are in agreement with our model that defects in β-AR response and renin secretion are responsible for the loss of blood pressure variation in Trpm6fl/fl;Six2-Cre mice.

Fig. 6: Effect of artificial intervention on circadian rhythms of blood pressure.
figure6

2- to 4-month-old WT mice were (a) administered with 25 mg/kg/day aliskiren via subcutaneously embedded osmotic minipump, b subjected to renal denervation, or c fed high-Mg diet, and blood pressure values were measured with radiotelemetry. Data are shown as means ± SEM for systolic (left) and diastolic (right) pressure values (n = 3 mice for each condition). The p-values were determined by two-way ANOVA with Holm-Sidak post hoc tests. *p < 0.05, **p < 0.01, ***p < 0.001.

We also tested the effect of elevating dietary magnesium content. For this purpose, wild-type mice fed a high-Mg diet containing 0.6% (normal diet: 0.3% magnesium) for 1 month. As expected, those mice showed elevated blood Mg level (Supplementary Fig. 8a). We then checked the expression level of TRPM6 at DCT; it decreased drastically by feeding high-Mg diet (Supplementary Fig. 8b, c), and the extent of decreased TRPM6 expression was larger than renal Cnnm2 ablation. When we measured the blood pressure in these mice, we found that mice fed a high-Mg diet showed significantly smaller blood pressure variation (Fig. 6c) as Trpm6-deficient mice, which is consistent with our notion that renal TRPM6 is important for circadian blood pressure variation.

Discussion

In this study, we demonstrated the importance of TRPM6 in the regulation of blood pressure. In particular, we show almost complete disappearance of the circadian variation of blood pressure in kidney-specific Trpm6-deficient mice. We also found that secretion of renin, a key hormone orchestrating blood pressure, was severely abrogated in Trpm6-deficient mice, which is consistent with the observed blood pressure phenotype. Several reports have shown that TRPM7, another Mg2+-permeable channel closely similar to TRPM6, also affects blood pressure37,38. TRPM7 prevents the increase of blood pressure upon Angiotensin II administration by suppressing the response of vascular endothelial cells to Angiotensin II37. To the contrary, it was recently reported that TRPM7 also facilitates the elevation of blood pressure upon leptin administration by mediating Mg2+ influx into the carotid body cells38. Thus, the role of TRPM7 in blood pressure regulation is ambiguous. However, since the expression level of TRPM7 in the kidney was not affected by renal Trpm6 ablation (Supplementary Fig. 5), it appears that TRPM7 is not directly involved in the phenotypes observed in this study.

As observed in Cnnm2-deficient mice, blood pressure values were reduced in Trpm6-deficient mice (Fig. 2)14. However, it should be noted that there was a clear difference between these mice. Cnnm2 disruption generally reduced blood pressure, but circadian variation was still clearly observable. In contrast, this variation disappeared in Trpm6-deficient mice. Such a qualitative difference is also consistent with our observation that the circadian variation of renin was preserved in Cnnm2-deficient mice (Supplementary Fig. 9). It should be noted that both CNNM2 and TRPM6 are thought to be important for renal Mg2+ reabsorption by mediating the vectorial Mg2+ transport through the DCT, and indeed, mice deficient in either gene exhibited identical renal Mg2+-wasting phenotype (Fig. 1 and ref. 39). The qualitative difference of blood pressure phenotype between Cnnm2- and Trpm6-deficient mice suggests that Mg2+ transport in the DCT, the common function of the two molecules, is not directly involved in the circadian variation of blood pressure and renin secretion, suggesting that the CNNM2-independent role of TRPM6 underlies these intriguing phenotypes.

Several mechanisms work to stimulate renin secretion from JG cells to maintain blood pressure. Among them, the input from renal sympathetic neurons is considered to play the principal role in augmenting blood pressure during the active period of circadian variation32. These neurons secrete noradrenalin, which binds to and activates β-AR on JG cells to stimulate cAMP production, ultimately leading to renin secretion17,32. In our experiments using kidney slices obtained from Trpm6-deficient mice, stimulation with isoproterenol, a β-AR agonist, showed no effect on renin secretion, while stimulation with PGE2 or db-cAMP efficiently increased renin secretion (Fig. 4). PGE2 is secreted by the macula densa in response to low levels of urinary Cl and it activates EP2 and EP4 receptors on JG cells, which, like β-AR activation, ultimately stimulates cAMP production40. Therefore, these results imply that β-AR signaling is selectively abrogated in JG cells of Trpm6-deficient mice, without affecting the downstream cAMP-mediated signaling pathway. Consistently, immunofluorescence of mouse kidney sections and immunoblotting of isolated JG cells revealed that β-AR expression was significantly decreased in the JG cells of Trpm6-deficient mice (Fig. 5). Such reduced β-AR expression should make JG cells unable to secrete renin in response to sympathetic nerve stimulation during the active period, thereby eliminating circadian variation of blood renin level and blood pressure. It should be noted that there is a study using β1/β2-AR knockout mice, which showed decreased circadian blood pressure variation as Trpm6-deficient mice41. They ascribed it to the decreased locomotor activity, but it remains possible that reduced circadian variation of renin activity contributes to decreased circadian variation of blood pressure. Alternatively, the unusual background of their mice (mixed background of C57BL6/J, 129, and FVB; we used pure C57BL6/J background) might mask the effect of β-AR on blood pressure variation; genetic backgrounds are critical for circadian blood pressure variation42.

How the loss of TRPM6 in DCT cells leads to the decreased β-AR expression in JG cells has remained elusive. Experiments using other types of cells have shown that β-AR expression is regulated by various molecules known to mediate intercellular signaling: Addition of glucocorticoids to the culture medium of vas deferens-derived cell line DDT1 MF-2 increases β-AR expression43. Also, it was reported that nitric oxide (NO) suppressed β-AR degradation in cardiac cells through S-nitrosylation of GRK244. Among these molecules, it is noteworthy that NO is secreted from renal macula densa cells, stimulating JG cells in a paracrine manner to increase renin secretion45. While the expression of nNOS, the NO producing enzyme in the kidney, is restricted to macula densa cells, they are in direct contact with DCT cells, the next segment of the renal tubule16. Thus, it is possible that Trpm6-deficiency in DCT cells leads to the decreased β-AR expression in JG cells by affecting the production or release of NO from the adjacent macula densa cells.

It is known that JG cells also communicate with other cells by forming gap junctions with surrounding cells, such as mesangial cells, and receive Ca2+ to suppress renin secretion17. Although JG cells and DCT cells do not directly contact with each other, they are still closely located (ref. 46 and Fig. 3) and it is possible that these cells use gap junctional communications through intervening cells, such as mesangial cells; all three cell types reportedly express Cx3747,48, a connexin isoform that oligomerizes and constitutes gap junctions. Further analysis may identify the molecule and the route responsible for the intercellular signaling between DCT and JG cells, which is important to unveil the overall mechanism of disrupted circadian blood pressure variation by Trpm6-deficiency.

In Trpm6-deficient mice, the circadian variation of blood levels of not just renin but also noradrenaline disappeared (Fig. 2e). Activation of the renin–angiotensin system stimulates the release of noradrenaline to the bloodstream29,30, and thus, it seems reasonable that the effect of Trpm6 ablation on blood renin and noradrenaline levels was similar. Since noradrenaline also acts on the β-AR of JG cells to promote renin secretion, the two molecules are assumed to constitute a positive feedback loop, stimulating each other’s secretion. However, it should be noted that the results of isoproterenol administration experiments explicitly show the defect in renin secretion (Fig. 4), and thus it seems to be the primary cause of the loss of the circadian variation of both renin and noradrenalin.

Thus far, a variety of effective drugs have been developed and used to treat hypertensive patients. However, a significant number of patients show resistance to the conventional treatments that use a combination of major antihypertensive drugs of different functional mechanisms49. Surgical denervation of renal sympathetic neurons using endovascular catheters has been conducted on a trial basis to treat such resistant hypertension50. Its practical effectiveness at improving blood pressure control has been controversial51,52, but recently published studies have shown a significant reduction in blood pressure compared with sham controls53,54. There are also mixed results on the effect of renal denervation on circadian variation of blood pressure. Some reports showed that the extent of blood pressure decrease by renal denervation was larger during the active periods53, but others reported no change in circadian variation of blood pressure55,56. In the analysis using laboratory animals, our renal denervation operations against mice suppressed the circadian variation of blood pressure (Fig. 6). Similar operations were also performed against rats, but even control wild-type rats show almost no circadian blood pressure variation in the first place57,58, making it difficult to evaluate the effect of the operation. More studies are required to make clear the impact of renal denervation on circadian blood pressure variation, which would also help us to understand the more detailed mechanism of blood pressure dysregulation by Trpm6-deficiency.

Methods

Animals

Cnnm2fl/fl;Six2-Cre, Cnnm2+/Δ, Cnnm4Δ/Δ, and control mice were generated in our previous studies14,20,59. Trpm6-deficient mouse strains were generated from an ES cell clone carrying the recombinant allele of Trpm6, Trpm6 (ID: EPD0741_2_G10, purchased from Knockout Mouse Project [KOMP]). Germline chimeras from this ES cell were bred with wild-type C57BL6/J mice to obtain Trpm6+/ mice. Trpm6+/ mice were then bred with FlpO mice59 to obtain mice with the Trpm6-floxed allele, Trpm6fl, and were subsequently crossed with Six2-Cre mice to obtain Trpm6fl/fl;Six2-Cre mice. Genotyping PCR was performed using the primers listed in Supplementary Table 1. Mice were maintained in individually ventilated cages in a specific pathogen-free, temperature controlled (20–26 °C) facility with a 12-h light/dark cycle. Age- and sex-matched male and female mice (2–4-month-old) were used in each independent experiment. All mouse experiments were conducted in accordance with the Guidelines of Proper Conduct of Animal Experiments (issued by the Science Council of Japan) after the receipt of approvals from the Animal Care and Use Committee of the Research Institute for Microbial Diseases, Osaka University, Japan.

Expression constructs

Human Trpm6 complementary DNA (cDNA) was purchased from Dharmacon (IMAGE: 100062461). The cDNA fragment was inserted into pCMV-Tag2B (Agilent) for expression in mammalian cells.

Antibodies and chemicals

The anti-NCC guinea pig polyclonal antibody (1/500 dilution for immunofluorescence analyses) was kindly provided by Dr. Shinichi Uchida (Tokyo Medical and Dental University)60. Anti-CNNM2 (1/2,000 dilution for immunoblotting analyses and 1/200 for immunofluorescence analyses) and anti-CNNM4 (1/2,000 dilution for immunoblotting analyses) rabbit polyclonal antibodies were generated in our previous studies14,20. The anti-TRPM6 rabbit polyclonal antibody (1/300 dilution for immunofluorescence analyses) was generated by immunizing rabbits with the bacterially expressed His-tagged TRPM6 (1270–1453 a.a.) proteins and purified using the bacterially expressed GST-tagged TRPM6 recombinant proteins (1270–1497 a.a.). The following commercially available primary antibodies were used: anti-NCC antibody (AB3553; Millipore, 1/5,000 dilution for immunoblotting analyses), anti-phospho-NCC antibody (S995B; University of Dundee, 1/500 dilution for immunoblotting analyses), anti-TRPM6 antibody (AP8053C; Abgent, 1/5,000 dilution for immunoblotting analyses), anti-renin antibody (ISASRREN-GF; Innovative Research, 1/500 dilution for immunofluorescence analyses), anti-renin antibody (AF4277; R&D Systems, 1/1000 dilution for immunoblotting analyses), anti-nNOS antibody (160870; Cayman, 1/500 dilution for immunofluorescence analyses), anti-AGT antibody (28101; IBL, 1/100 dilution for immunoblotting analyses), anti-β1-AR antibody (PA1049; Invitrogen, 1/1000 dilution for immunoblotting analyses and 1/100 dilution for immunofluorescence analyses), anti-GFP antibody (A11122; Invitrogen, 1/3000 dilution for immunoblotting analyses), and anti-β-tubulin and anti-FLAG antibodies (T4026 and F1804, respectively; Sigma, both 1/5000 dilution for immunoblotting analyses). We used the following commercially available secondary antibodies: Alexa Fluor 488-conjugated anti-rabbit and anti-sheep antibodies and Alexa Fluor 568-conjugated anti-rabbit and anti-guinea pig antibodies (Life Technologies) for immunofluorescence analyses (all 1/2000 dilution), alkaline phosphatase-conjugated anti-rabbit, anti-goat, and anti-mouse antibodies (Promega, all 1/10,000 dilution), HRP-conjugated anti-sheep antibody (Pierce, 1/10,000 dilution), and Clean-Blot IP Detection Kit (for immunoprecipitated samples; Thermo Fisher, 1/200 dilution) for immunoblotting analyses.

We used the following commercially available chemicals: isoproterenol (I6504; Sigma), PGE2 (14010; Cayman), db-cAMP (023-16381; Wako), and aliskiren (A4534; LKT).

Validation of anti-TRPM6 antibody

The specificity of the house made anti-TRPM6 antibody used for immunofluorescence analyses (Figs. 1b, 3b, and 3e and Supplementary Figs. 1c, 1e, and 8c) was validated by successive immunoprecipitation and immunoblotting analyses as follows (Supplementary Fig. 10)61. To reduce the background noise level due to the antibody itself, the anti-TRPM6 antibody was covalently linked to Protein A agarose beads (Thermo Fisher) by incubating with 20 mM dimethylpimelimidate (Sigma) for 30 min at room temperature. Then, the beads were mixed with lysates of cells or mouse organs. Lysates were prepared by solubilizing cells or tissues in lysis buffer (20 mM Tris-HCl [pH 7.5], 0.5% Triton X-100, 150 mM NaCl, 2 mM EDTA, supplemented with cOmplete Protease Inhibitor Cocktail [Roche]). The beads were rotated overnight at 4 °C, washed five times with lysis buffer, and the resultant immunoprecipitates were subjected to immunoblotting analyses. To reduce the background noise level due to the precipitated antibody, the Clean-Blot IP Detection Kit was used, which selectively reacts to native IgGs (primary antibodies) but not to denatured IgGs as secondary antibodies.

Cell culture

MDCT cells21, kindly provided by Dr. Kouichi Tamura (Yokohama City University) and Dr. Peter A. Friedman (University of Pittsburgh), were cultured in Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s F-12 Medium (1:1 mixture), supplemented with 5% fetal bovine serum (FBS) and antibiotics. HEK293 cells were routinely maintained in our laboratory and cultured in DMEM plus 10% FBS and antibiotics. Cell cultures under low-magnesium conditions were performed with magnesium/calcium-free DMEM (Thermo Fisher) supplemented with PBS-dialyzed FBS, 1.8 mM CaCl2, and the indicated concentrations of MgCl2. Expression plasmids and siRNAs were transfected into cells using LipofectAmine2000 (Invitrogen) or LipofectAmine RNAiMAX (Invitrogen), respectively.

RNAi knockdown

Duplex siRNAs against mouse Cnnm2 and Cnnm4 were purchased from Sigma and Invitrogen, respectively. The target sequences were as follows: Cnnm2-siRNA, 5′-CCATTGTGCAGCGAGTGAA-3′ and Cnnm4-siRNA, 5′-GGTGGACGAG ACCACAACTCTT-3′. A non-targeting siRNA sequence was used as a control (negative control LO GC, Invitrogen).

Elemental quantitation

Elemental quantification was done as follows20. Urine was collected by housing each mouse in metabolic cages (CLEA Japan) after 1 week acclimation. For serum samples, whole blood was collected from the abdominal aorta and incubated for 30 min at room temperature. Serum was then collected by centrifugation. Each element was quantified either by Xylidyl Blue-I (Mg, Wako) or ICP-ES (Mg, Ca, Na, and K; ICPS-8100; Shimadzu).

Hormone quantitation

Whole blood was collected from the abdominal aorta in EDTA-containing tubes and plasma was isolated by centrifugation. Plasma renin activity was measured using a fluorescence renin assay kit (Abcam) and a microplate reader (SH-9000 controlled by SF61 software; both from Corona electric). Plasma AVP and noradrenaline levels were quantitated using Arg8-Vasopressin ELISA kit (Enzo Life Sciences) and Norepinephrine ELISA Kit (LDN), respectively, and the abovementioned microplate reader.

Microarray analyses

Microarray analyses were performed with the following protocol62. Kidneys were dissected from 2-month-old Cnnm2+/+;Six2-Cre or Cnnm2fl/fl;Six2-Cre mice and total RNA was extracted using the RNeasy Extraction Kit (Qiagen). Dye-swapped experiments were performed by hybridizing complementary RNA (cRNA), labeled with either cyanine (Cy) -3 or Cy-5 (Perkin-Elmer), onto a Whole Mouse Genome Oligo Microarray 4 × 44 K ver.2 (G4846A; Agilent Technologies). Data were submitted to the NCBI Gene Expression Omnibus (GEO), with accession number, GSE73490. The genes (p < 0.1, two-tailed Student’s t-test, paired) with mean fold-changes > +2.0 or < −2.0 (“+” indicates upregulated and “−” indicates downregulated for each absolute value) in both experiments are listed in Table 1.

PCR analyses

For cDNA synthesis63, RNA from mouse tissues or MDCT cells was prepared with RNAiso Plus (Takara), and cDNA was synthesized from 2 μg RNA with revertra ace (Toyobo). Semi-quantitative PCR analyses of mouse CNNMs64 were performed with a thermal cycler (T100; Bio-Rad) using Ex-taq (Takara). As a positive control, we also included samples using plasmid vectors containing the cDNA region of each mouse Cnnm as templates. Real-time qPCR experiments62 were performed with MiniOpticon (Bio-Rad) using the iQ SYBR green Supermix (Bio-Rad) as a reagent, and the data were obtained under the control of Opticon Monitor software (Bio-Rad). The quality of the final PCR product was confirmed by agarose gel electrophoresis. No obvious non-specifically amplified DNAs were observed. The primer sets used are listed in Supplementary Table 1.

[Mg2+]i measurement

For [Mg2+]i measurement20, cells were loaded with 2 μM Mag-fura2-AM (Invitrogen) in serum-free DMEM for 45 min at 37 °C. After washing with serum-free DMEM, the cells were viewed using the IX81 microscope (Olympus) equipped with a CMOS camera (ORCA-Flash 4.0; Hamamatsu Photonics) and a mercury lamp (USH-1030L; Olympus). The fluorescence images were acquired under the control of metamorph software (Molecular Device) with excitation wavelength of 330 − 350 nm and 370 − 390 nm, and emission wavelength of 505 − 545 nm, respectively. [Mg2+]i was determined from the following formula [Mg2+]i = KdQ × (R − Rmin)/Rmax, where R is the ratio of the signal intensity with 330 − 350 nm excitation (F1) to that with 370 − 390 nm excitation (F2) (R = F1/F2), Rmax is the maximum value of R, Rmin is the minimum value of R, Q is the ratio of the signal intensity with 370 − 390 nm excitation when Rmin was obtained to the signal intensity with 370 − 390 nm excitation when Rmax was obtained (F2min/F2max), and we used 1.5 mM as the Kd value20. The value of Rmin, Rmax, F2min, and F2max were obtained after each experiment. The cells were incubated in serum-free DMEM supplemented with 6 μM 4-Bromo-A23187 (Wako) and 10 mM EDTA, and the fluorescent images were acquired to obtain Rmin and F2min values. Subsequently, the media was replaced with serum-free DMEM supplemented with 6 μM 4-Bromo-A23187 and 50 mM MgCl2, and the fluorescent images were acquired to obtain Rmax and F2max values. For [Mg2+]i measurement of cells cultured under various extracellular Mg2+ conditions, loading of Mag-fura2, washing, and data acquisition was performed by bathing the cells with magnesium/calcium-free DMEM (Thermo Fisher) supplemented with 1.8 mM CaCl2 and the indicated concentrations of MgCl2.

Kidney slice preparation

By referring to several studies65,66,67, kidney slices were prepared as follows. Kidneys dissected from 2- to 3-month-old mice were immediately placed on ice-cold saline, and slices (0.4 mm thick) were cut using a vibratory tissue slicer (DTK-1000, Dosaka EM). Slices were preincubated in Krebs-Ringer bicarbonate solution (KRBS; 118.5 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, 10 mM Glucose, saturated with 95% O2/5% CO2 and adjusted to pH 7.4) at 37 °C for 15 min. After washing with KRBS, slices were incubated for a further 30 min at 37 °C in fresh KRBS containing chemical stimulants. Slices were then fixed with ice-cold 2% paraformaldehyde (PFA) in PBS for 2 h and subjected to immunofluorescence analyses.

Immunofluorescence analyses of tissue sections

Whole kidneys or kidney slices from 2-month-old mice were embedded in OCT compound (Sakura Finetechnical), frozen in liquid nitrogen, and then cut into 20- or 30-µm sections using a cryostat (Leica). Sections were mounted on glass slides, air-dried, and fixed with ice-cold 2% PFA in PBS for 10 min. For subsequent immunostaining62,64, the sections were blocked twice in PBSMT (2% skim milk, 0.3% Triton X-100 in PBS) for 1 h at 4 °C. Then, the specimens were incubated with primary antibody diluted in PBSMT for overnight at 4 °C. After 7 washes with PBSMT, the specimens were incubated with appropriate fluorophore-conjugated secondary antibodies for overnight at 4 °C. Nuclei were also stained with 4’,6-diamidino-2-phenylindole (DAPI). After seven washes with PBSMT, the sections were observed with a confocal scanning laser microscope (FLUOVIEW FV1000; Olympus) under the control of FV10-ASW software (Olympus).

Telemetric measurements of blood pressure, heart rate, and locomotor activity

Telemetric measurements of blood pressure were performed as follows14. Blood pressure transducers (TA11PA-C10, Data Sciences International) were surgically inserted into the left common carotid artery of 2- to 3-month-old mice under anesthesia (by intraperitoneal administration of 0.3 mg/kg medetomidine, 4 mg/kg midazolam, and 5 mg/kg butorphanol). After 3 weeks of recovery, systolic and diastolic blood pressure values were recorded with a 2-min scheduled sampling every 60 min by using Dataquest ART software (Data Sciences International). Records were obtained for at least five consecutive days, and the averages of measurements taken at the same time each day were determined for each mouse and used for further statistical analyses, except for Supplementary Fig. 4. Based on Nakamori et al.68, renal denervation was performed 2 weeks before inserting blood pressure transducers as follows. Kidneys were exposed by abdominal incision and connective tissue around the renal vessels was dissected. Then, the renal vessels were immersed in 95% ethanol for 2 min and thereafter, in PBS for 2 min. Sham operation was performed using the equivalent procedure without ethanol immersion. Aliskiren was administered 25 mg/kg/day by subcutaneously embedding an osmotic pump (1004, ALZET), and recording was started from the day after pump introduction. For magnesium supplementation, mice were fed a magnesium-enriched diet containing 0.6% magnesium (CLEA Japan) for 1 month before blood pressure measurement.

Heart rate was measured with the same radiotelemetry system, except that the recording was performed with a 30-s scheduled sampling every minute, and a single measurement was used for further analysis.

Locomotor activities were assessed using the same radiotelemetry system, by monitoring the changes in signal strength from the transducer due to the animal’s locomotion. In this case, transducers were surgically inserted into the subcutaneous space in the right flank. Recordings were performed with the same time intervals as described above.

Isolation of JG cells

JG cells were isolated according to the method reported by Della Bruna and colleagues35, with several minor modifications. Kidneys from four mice were minced and incubated in buffer 1 (130 mM NaCl, 5 mM KC1, 2 mM CaCl2, 10 mM glucose, 20 mM sucrose, 10 mM Tris-HCl [pH 7.4]) supplemented with 0.25% trypsin and 0.1 % collagenase at 37 °C for 2 h. After filtration with a cell strainer (40 μm pore size, Falcon), cells were washed with buffer 1 and mixed with 20× volume of 30% isoosmotic Percoll solution. Centrifugation at 27,000 × g for 25 min yielded three bands, and each band was collected and used for further analyses.

Statistical analyses

All statistical analyses were performed using Prism software (GraphPad) after data analyses with Microsoft Excel 11, Metamorph (Molecular Device), or Dataquest ART (Data science international). Circadian pattern was determined by cosinor analyses, which fits the data to the following formula y  = BaseLine + Amplitude × cos ([x – PhaseShift] × π/12). All statistical data are presented as means ± SEM and p-values were obtained by either Student’s two-tailed t-test, one- or two-way ANOVA with Holm-Sidak post hoc test, or chi-square test, as described in the figure legends.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Data availability

Microarray data were deposited to the NCBI Gene Expression Omnibus (GEO), with accession number GSE73490. The other source data supporting the findings of this study are publicly available in figshare [https://doi.org/10.6084/m9.figshare.14544510]. Raw data are provided within source data file. Source data are provided with this paper.

References

  1. 1.

    Giles, T. D. Circadian rhythm of blood pressure and the relation to cardiovascular events. J. Hypertens. 24, S11–S16 (2006).

    CAS  Article  Google Scholar 

  2. 2.

    Smolensky, M. H., Portaluppi, F. & Hermida, R. C. in Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, 3rd edn. (eds White, W. B.) Part II, Ch. 6, 105–128 (Springer, 2016).

  3. 3.

    Witteman, J. C. et al. A prospective study of nutritional factors and hypertension among US women. Circulation 80, 1320–1327 (1989).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  4. 4.

    Ascherio, A. et al. A prospective study of nutritional factors and hypertension among US men. Circulation 86, 1475–1484 (1992).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  5. 5.

    Ascherio, A. et al. Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27, 1065–1072 (1996).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  6. 6.

    Song, Y. et al. Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10-year follow-up study. Am. J. Cardiol. 98, 1616–1621 (2006).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  7. 7.

    Joosten, M. M. et al. Urinary and plasma magnesium and risk of ischemic heart disease. Am. J. Clin. Nutr. 97, 1299–1306 (2013).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  8. 8.

    Giménez-Mascarell, P., Schirrmacher, C. E., Martínez-Cruz, L. A. & Müller, D. Novel aspects of renal magnesium homeostasis. Front. Pediatr. 6, 77 (2018).

    PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Schlingmann, K. P. et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat. Genet. 31, 166–170 (2002).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Walder, R. Y. et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat. Genet. 31, 171–174 (2002).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  11. 11.

    Voets, T. et al. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J. Biol. Chem. 279, 19–25 (2004).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  12. 12.

    Stuiver, M. et al. CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia. Am. J. Hum. Genet. 88, 333–343 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    de Baaij, J. H. et al. Membrane topology and intracellular processing of cyclin M2 (CNNM2). J. Biol. Chem. 287, 13644–13655 (2012).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  14. 14.

    Funato, Y., Yamazaki, D. & Miki, H. Renal function of cyclin M2 Mg2+ transporter maintains blood pressure. J. Hypertens. 35, 585–592 (2017).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Hirata, Y., Funato, Y., Takano, Y. & Miki, H. Mg2+-dependent interactions of ATP with the cystathionine-β-synthase (CBS) domains of a magnesium transporter. J. Biol. Chem. 289, 14731–14739 (2014).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    McCormick, J. A. & Ellison, D. H. Distal convoluted tubule. Compr. Physiol. 5, 45–98 (2015).

    PubMed  PubMed Central  Google Scholar 

  17. 17.

    Kurtz, A. Renin release: sites, mechanisms, and control. Annu. Rev. Physiol. 73, 377–399 (2011).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Friis, U. G. et al. Regulation of renin secretion by renal juxtaglomerular cells. Pflug. Arch. 465, 25–37 (2013).

    CAS  Article  Google Scholar 

  19. 19.

    Bindels, R. J., Hartog, A., Timmermans, J. A. & van Os, C. H. Immunocytochemical localization of calbindin-D28k, calbindin-D9k and parvalbumin in rat kidney. Contrib. Nephrol. 91, 7–13 (1991).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  20. 20.

    Yamazaki, D. et al. Basolateral Mg2+ extrusion via CNNM4 mediates transcellular Mg2+ transport across epithelia: a mouse model. PLoS Genet. 9, e1003983 (2013).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  21. 21.

    Gesek, F. A. & Friedman, P. A. Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J. Clin. Invest. 90, 429–438 (1992).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Groenestege, W. M., Hoenderop, J. G., van den Heuvel, L., Knoers, N. & Bindels, R. J. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J. Am. Soc. Nephrol. 17, 1035–1043 (2006).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    Wolf, F. I. et al. Modulation of TRPM6 and Na(+)/Mg(2+) exchange in mammary epithelial cells in response to variations of magnesium availability. J. Cell Physiol. 222, 374–381 (2010).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  24. 24.

    Chubanov, V. et al. Epithelial magnesium transport by TRPM6 is essential for prenatal development and adult survival. Elife 5, e20914 (2016).

    PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Walder, R. Y. et al. Mice defective in Trpm6 show embryonic mortality and neural tube defects. Hum. Mol. Genet. 18, 4367–4375 (2009).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Kobayashi, A. et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 3, 169–181 (2008).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  27. 27.

    Greeley, G. H. Jr., Morris, M., Eldridge, J. C. & Kizer, J. S. A diurnal plasma vasopressin rhythm in rats. Life Sci. 31, 2843–2846 (1982).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  28. 28.

    Pizarro, A., Hayer, K., Lahens, N. F. & Hogenesch, J. B. CircaDB: a database of mammalian circadian gene expression profiles. Nucleic Acids Res. 41, D1009–D1013 (2013).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Feuerstein, G. et al. Angiotensin II mediation of adrenal catecholamine secretion induced by intrarenal isoprenaline infusion. Eur. J. Pharmacol. 52, 375–377 (1978).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  30. 30.

    Farrell, D. M. et al. Angiotensin II modulates catecholamine release into interstitial fluid of canine myocardium in vivo. Am. J. Physiol. Heart Circ. Physiol. 281, H813–H822 (2001).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  31. 31.

    Kim, H. S., Lee, G., John, S. W., Maeda, N. & Smithies, O. Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration. Proc. Natl Acad. Sci. USA 99, 4602–4607 (2002).

    ADS  CAS  PubMed  Article  PubMed Central  Google Scholar 

  32. 32.

    Kopp, U. C. Neural Control of Renal Function (Morgan & Claypool Life Sciences, 2011).

  33. 33.

    Franco-Saenz, R., Suzuki, S., Tan, S. Y. & Mulrow, P. J. Prostaglandin stimulation of renin release: independence of beta-adrenergic receptor activity and possible mechanism of action. Endocrinology 106, 1400–1404 (1980).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Boivin, V. et al. Immunofluorescent imaging of beta 1- and beta 2-adrenergic receptors in rat kidney. Kidney Int. 59, 515–531 (2001).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  35. 35.

    Della Bruna, R., Pinet, F., Corvol, P. & Kurtz, A. Regulation of renin secretion and renin synthesis by second messengers in isolated mouse juxtaglomerular cells. Cell Physiol. Biochem 1, 98–110 (1991).

    Article  Google Scholar 

  36. 36.

    Jensen, C., Herold, P. & Brunner, H. R. Aliskiren: the first renin inhibitor for clinical treatment. Nat. Rev. Drug Discov. 7, 399–410 (2008).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  37. 37.

    Antunes, T. T. et al. Transient receptor potential melastatin 7 cation channel kinase: new player in angiotensin II-induced. Hypertension 67, 763–773 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Shin, M. K. et al. Leptin induces hypertension acting on transient receptor potential melastatin 7 channel in the carotid body. Circ. Res. 125, 989–1002 (2019).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Funato, Y., Furutani, K., Kurachi, Y. & Miki, H. CNNM proteins are Na+ /Mg2+ exchangers playing a central role in transepithelial Mg2+ (re)absorption. J. Physiol. 596, 743–746 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  40. 40.

    Friis, U. G. et al. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells. Am. J. Physiol. Ren. Physiol. 289, F989–F997 (2005).

    ADS  CAS  Article  Google Scholar 

  41. 41.

    Kim, S. M. et al. Persistence of circadian variation in arterial blood pressure in beta1/beta2-adrenergic receptor-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1427–R1434 (2008).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Basset, A., Laude, D., Laurent, S. & Elghozi, J. L. Contrasting circadian rhythms of blood pressure among inbred rat strains: recognition of dipper and non-dipper patterns. J. Hypertens. 22, 727–737 (2004).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  43. 43.

    Hadcock, J. R. & Malbon, C. C. Regulation of beta-adrenergic receptors by “permissive” hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc. Natl Acad. Sci. USA 85, 8415–8419 (1988).

    ADS  CAS  PubMed  Article  PubMed Central  Google Scholar 

  44. 44.

    Whalen, E. J. et al. Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129, 511–522 (2007).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  45. 45.

    Castrop, H. et al. Physiology of kidney renin. Physiol. Rev. 90, 607–673 (2010).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  46. 46.

    Latta, H. & Maunsbach, A. B. The juxtaglomerular apparatus as studied electron microscopically. J. Ultrastruct. Res. 6, 547–561 (1962).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    Zhang, J. & Hill, C. E. Differential connexin expression in preglomerular and postglomerular vasculature: accentuation during diabetes. Kidney Int. 68, 1171–1185 (2005).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  48. 48.

    Stoessel, A., Himmerkus, N., Bleich, M., Bachmann, S. & Theilig, F. Connexin 37 is localized in renal epithelia and responds to changes in dietary salt intake. Am. J. Physiol. Ren. Physiol. 298, F216–F223 (2010).

    CAS  Article  Google Scholar 

  49. 49.

    Cai, A. & Calhoun, D. A. Resistant hypertension: an update of experimental and clinical findings. Hypertension 70, 5–9 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Krum, H. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373, 1275–1281 (2009).

    PubMed  Article  PubMed Central  Google Scholar 

  51. 51.

    Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376, 1903–1909 (2010).

    Article  Google Scholar 

  52. 52.

    Bhatt, D. L. et al. A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med. 370, 1393–1401 (2014).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  53. 53.

    Azizi, M. et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet 391, 2335–2345 (2018).

    PubMed  Article  PubMed Central  Google Scholar 

  54. 54.

    Kandzari, D. E. et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 391, 2346–2355 (2018).

    PubMed  Article  PubMed Central  Google Scholar 

  55. 55.

    Kario, K. et al. Twenty-four-hour ambulatory blood pressure reduction patterns after renal denervation in the SPYRAL HTN-OFF MED trial. Circulation 138, 1602–1604 (2018).

    PubMed  Article  PubMed Central  Google Scholar 

  56. 56.

    de la Sierra, A. et al. Renal denervation vs. spironolactone in resistant hypertension: effects on circadian patterns and blood pressure variability. Am. J. Hypertens. 30, 37–41 (2017).

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  57. 57.

    Katayama, T. et al. Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome. J. Am. Heart Assoc. 2, e000197 (2013).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  58. 58.

    Becker, B. K. et al. Renal denervation attenuates hypertension but not salt sensitivity in ETB receptor-deficient rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 313, R425–R437 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  59. 59.

    Yamazaki, D. et al. The Mg2+ transporter CNNM4 regulates sperm Ca2+ homeostasis and is essential for reproduction. J. Cell Sci. 129, 1940–1949 (2016).

    CAS  PubMed  PubMed Central  Google Scholar 

  60. 60.

    Ohno, M. et al. Immunolocalization of WNK4 in mouse kidney. Histochem. Cell Biol. 136, 25–35 (2011).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  61. 61.

    Hayashi, T. et al. Nucleoredoxin negatively regulates Toll-like receptor 4 signaling via recruitment of flightless-I to myeloid differentiation primary response gene (88). J. Biol. Chem. 285, 18586–18593 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  62. 62.

    Funato, Y. et al. Nucleoredoxin sustains Wnt/β-catenin signaling by retaining a pool of inactive dishevelled protein. Curr. Biol. 20, 1945–1952 (2010).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  63. 63.

    Funato, Y., Michiue, T., Asashima, M. & Miki, H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat. Cell Biol. 8, 501–508 (2006).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  64. 64.

    Funato, Y. et al. Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression. J. Clin. Invest. 124, 5398–5410 (2014).

    PubMed  PubMed Central  Article  Google Scholar 

  65. 65.

    Aoi, W., Wade, M. B., Rosner, D. R. & Weinberger, M. H. Renin release by rat kidney slices in vitro: effects of cations and catecholamines. Am. J. Physiol. 227, 630–634 (1974).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  66. 66.

    Naftilan, A. J. & Oparil, S. The role of calcium in the control of renin release. Hypertension 4, 670–675 (1982).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  67. 67.

    Matsumura, Y., Sasaki, Y., Shinyama, H. & Morimoto, S. The calcium channel agonist, Bay K 8644, inhibits renin release from rat kidney cortical slices. Eur. J. Pharmacol. 117, 369–372 (1985).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  68. 68.

    Nakamori, H. et al. Arterial wall hypertrophy is ameliorated by α2-adrenergic receptor antagonist or aliskiren in kidneys of angiotensinogen-knockout mice. Clin. Exp. Nephrol. 22, 773–781 (2018).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr. Kouichi Tamura (Yokohama City University) and Dr. Peter A. Friedman (University of Pittsburgh) for providing the MDCT cells, Dr. Shinichi Uchida (Tokyo Medical and Dental University) for providing the anti-NCC antibody, and Ms. Hiromi Yamamoto and Ms. Yayoi Tsumori (Osaka University) for technical supports. This work was supported by Salt Science Research Foundation Grant Numbers 1737 and 1832 to Y.F., and JSPS KAKENHI Grant Numbers JP26460364 and JP17K19396 to Y.F., JP26430113 and JP 17K08631 to D.Y., and JP26291042, JP26111007, JP16K14723, and JP17H04041 to H.M.

Author information

Affiliations

Authors

Contributions

H.M. and Y.F. conceived the study design. H.M. wrote the manuscript with contributions from Y.F. Y.F. performed the experiments with contributions from D.Y. in preparing the Cnnm4-deficient mice, from D.O. in the DNA microarray analyses, and from N.Y. in the kidney slice experiments. All the authors have read and approved the final manuscript.

Corresponding author

Correspondence to Hiroaki Miki.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information Nature Communications thanks Dmitri Firsov, Armin Kurtz, Rhian Touyz and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Source data

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Funato, Y., Yamazaki, D., Okuzaki, D. et al. Importance of the renal ion channel TRPM6 in the circadian secretion of renin to raise blood pressure. Nat Commun 12, 3683 (2021). https://doi.org/10.1038/s41467-021-24063-2

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing